EL4Z:XETRA:XETRA-Deka MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 44.874

Change

-0.73 (-1.61)%

Market Cap

USD 0.33B

Volume

9.99K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.29 (+0.58%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.51%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.27 (+1.02%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.17%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.16 (+0.66%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.60 (+1.05%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+0.58 (+0.42%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.70%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.28 (+0.55%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.54 (-0.11%)

USD 80.38B

ETFs Containing EL4Z:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.65% 84% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.65% 84% B 81% B-
Trailing 12 Months  
Capital Gain 26.09% 87% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.09% 87% B+ 86% B+
Trailing 5 Years  
Capital Gain 83.08% 92% A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.08% 92% A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 12.57% 86% B+ 82% B
Dividend Return 13.03% 87% B+ 82% B
Total Return N/A 53% F 62% D
Risk Return Profile  
Volatility (Standard Deviation) 14.76% 41% F 52% F
Risk Adjusted Return 88.32% 97% N/A 96% N/A
Market Capitalization 0.33B 60% D- 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.